Clin2
NCT07857473Possibly a fitNot yet recruiting

Weight loss study for overweight or obese adults

Overweight and Obesity

Part of Hormones & metabolism clinical trials.

This study tests an investigational drug called TE-8105 to see if it is safe and effective for helping adults who are overweight or obese lose weight. It may be an option for you if you are looking for a medical approach to weight management.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
204 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be an adult with a body mass index (BMI) between 25 and 34.9, or have a weight-related condition such as high blood pressure, high cholesterol, heart disease, or type 2 diabetes.
  • Your weight must have been stable for the past few months (less than a 5% change).
  • You must be generally healthy aside from being overweight or obese.
  • You cannot have had weight-loss surgery or used certain weight-loss medications recently.
  • If you are female, you must not be pregnant or breastfeeding, and you must use effective birth control if you can become pregnant. If you are male, you must agree to use condoms and not donate sperm during the study.
  • You must not have certain medical conditions like type 1 diabetes, severe kidney or liver disease, or a history of certain thyroid or heart problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07230496Recruiting· Phase 1
Safety study of an investigational weight-management drug

This study is testing a new investigational drug, either alone or combined with another drug, to see how safe it is and how the body processes it. It is for healthy people who are overweight or obese, and results may help in developing future treatments for weight management.

Sydney, New South Wales
NCT07518589Not yet recruiting· Phase 1
Weight loss drug study for overweight adults

This study tests a new medication called CMS-D008 to see if it can help with weight loss in overweight or obese adults. It is an early-stage trial, so the main goals are to check safety and how the body handles the drug.

NCT07822061Recruiting· Phase 3
Weight loss study for people with excess weight

This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.

Sapporo, Hokkaido
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07841860Not yet recruiting· Phase 1
Weight loss study for healthy and obese adults

This study tests a new weight-loss medicine called HRS-1596. It is given as a tablet to see if it is safe and how well it works. The study first gives a single dose to healthy adults, then multiple doses to people with obesity.

Jinan, Shandong
NCT07378033Enrolling by invitation
Body fat reduction and weight management study

This study tests a new approach to help with weight loss and body fat reduction. It may be a good fit if you are an adult with a BMI in the overweight to moderately obese range and you are not currently using weight-loss medications.

Bangalore, Karnataka

Hear when a new Overweight and Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.